European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
Authors
Keywords
Guidelines, Radionuclide imaging, Phaeochromocytoma, Paraganglioma, Targeted radionuclide therapy, Positron emission tomography, Somatostatin analogues
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 46, Issue 10, Pages 2112-2137
Publisher
Springer Science and Business Media LLC
Online
2019-06-29
DOI
10.1007/s00259-019-04398-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-Prono study): an ENS@T retrospective study
- (2019) Segolene Hescot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genotype-phenotype correlations in pheochromocytoma and paraganglioma
- (2019) Joakim Crona et al. ENDOCRINE-RELATED CANCER
- The role of 68Ga-DOTA-Octreotate (GaTate) PET/CT in follow-up of SDH-associated pheochromocytoma and paraganglioma (PPGL)
- (2019) Grace Kong et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- 68Ga-somatostatin receptor analogs and 18F-FDG PET/CT in the localization of metastatic pheochromocytomas and paragangliomas with germline mutations: a meta-analysis
- (2018) Ying Kan et al. ACTA RADIOLOGICA
- Role of DOTATATE-PET/CT in preoperative assessment of phaeochromocytoma and paragangliomas
- (2018) Matti L. Gild et al. CLINICAL ENDOCRINOLOGY
- Clinical progression and metachronous paragangliomas in a large cohort of SDHD germline variant carriers
- (2018) Berdine L Heesterman et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Guidelines on nuclear medicine imaging in neuroblastoma
- (2018) Zvi Bar-Sever et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma
- (2018) David Taïeb et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Characterization of Noise and Resolution for Quantitative177Lu SPECT/CT with xSPECT Quant
- (2018) Johannes Tran-Gia et al. JOURNAL OF NUCLEAR MEDICINE
- Performance of68Ga-DOTA-Conjugated Somatostatin Receptor Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Meta-Analysis
- (2018) Sangwon Han et al. JOURNAL OF NUCLEAR MEDICINE
- Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression
- (2018) Martin H. Cherk et al. CANCER IMAGING
- Influence of lanreotide on uptake of 68Ga-DOTATATE in patients with neuroendocrine tumours: a prospective intra-patient evaluation
- (2018) E. A. Aalbersberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma
- (2018) Letizia Canu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
- (2017) Joakim Crona et al. ENDOCRINE REVIEWS
- Head-to-head comparison between 18F-FDOPA PET/CT and MR/CT angiography in clinically recurrent head and neck paragangliomas
- (2017) Céline Heimburger et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population
- (2017) Abhishek Jha et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Metanephrines for Evaluating Palpitations and Flushing
- (2017) Fady Hannah-Shmouni et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study
- (2017) Carole Guerin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review
- (2017) Ruth T Casey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma
- (2017) Grace Kong et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genetic status determines 18 F-FDG uptake in pheochromocytoma/paraganglioma
- (2017) Ankita Tiwari et al. Journal of Medical Imaging and Radiation Oncology
- The Evolving Role of Succinate in Tumor Metabolism: An18F-FDG–Based Study
- (2017) Philippe Garrigue et al. JOURNAL OF NUCLEAR MEDICINE
- Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes
- (2017) Ingo Janssen et al. JOURNAL OF NUCLEAR MEDICINE
- Biodistribution and Dosimetry of18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies
- (2017) Neeta Pandit-Taskar et al. JOURNAL OF NUCLEAR MEDICINE
- Somatostatin Receptor Antagonists for Imaging and Therapy
- (2017) Melpomeni Fani et al. JOURNAL OF NUCLEAR MEDICINE
- Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure
- (2017) Arnold F. Jacobson et al. NUCLEAR MEDICINE COMMUNICATIONS
- New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma
- (2017) David Taïeb et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Novel insights into the polycythemia–paraganglioma–somatostatinoma syndrome
- (2016) Roland Därr et al. ENDOCRINE-RELATED CANCER
- Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations
- (2016) Eleni Daniel et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
- (2016) Martin Fassnacht et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- New Fetal Dose Estimates from 18F-FDG Administered During Pregnancy: Standardization of Dose Calculations and Estimations with Voxel-Based Anthropomorphic Phantoms
- (2016) P. Zanotti-Fregonara et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-DOTATATE and 18F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
- (2016) Chian A. Chang et al. CANCER IMAGING
- Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma
- (2015) I. Janssen et al. CLINICAL CANCER RESEARCH
- Accuracy of 68Ga DOTANOC PET/CT Imaging in Patients With Multiple Endocrine Neoplasia Syndromes
- (2015) Punit Sharma et al. CLINICAL NUCLEAR MEDICINE
- Screening in asymptomatic SDHx mutation carriers: added value of 18F-FDG PET/CT at initial diagnosis and 1-year follow-up
- (2015) C. Lepoutre-Lussey et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective comparison of 68Ga-DOTATATE and 18F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases
- (2015) Aurélien Archier et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Impact of medications on mIBG uptake, with specific attention to the heart: Comprehensive review of the literature
- (2015) Arnold F. Jacobson et al. JOURNAL OF NUCLEAR CARDIOLOGY
- 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI
- (2015) I. Janssen et al. JOURNAL OF NUCLEAR MEDICINE
- Somatostatin Receptor Imaging with68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation
- (2015) Michael S. Hofman et al. RADIOGRAPHICS
- Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
- (2015) Lauren Fishbein et al. Nature Communications
- 68Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to 123I-MIBG SPECT/CT
- (2014) Alexander Kroiss et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
- (2014) Ronald Boellaard et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
- (2014) Jacques W. M. Lenders et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of Thyroid Blockade on Thyroid Radioiodine Uptake in 123I-mIBG Imaging
- (2014) N. C. Friedman et al. JOURNAL OF NUCLEAR MEDICINE
- Pheochromocytoma: The Range of Appearances on Ultrasound, CT, MRI, and Functional Imaging
- (2013) Katherine Leung et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC–PGL syndromes: a clinicopathological and molecular analysis
- (2013) Thomas G Papathomas et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma
- (2013) Alexander Kroiss et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Quantitative SPECT/CT: SPECT joins PET as a quantitative imaging modality
- (2013) Dale L. Bailey et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-DOTANOC PET/CT for Baseline Evaluation of Patients with Head and Neck Paraganglioma
- (2013) P. Sharma et al. JOURNAL OF NUCLEAR MEDICINE
- Comparative Biodistribution and Radiation Dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in Patients with Neuroendocrine Tumors
- (2013) M. Sandstrom et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma
- (2012) Mariam Jafri et al. CLINICAL ENDOCRINOLOGY
- Impact of Point Spread Function Reconstruction on Thoracic Lymph Node Staging With 18F-FDG PET/CT in Non–Small Cell Lung Cancer
- (2012) Charline Lasnon et al. CLINICAL NUCLEAR MEDICINE
- Is There an Optimal Scan Time for 6-[F-18]Fluoro-L-DOPA PET in Pheochromocytomas and Paragangliomas?
- (2012) Michael Hentschel et al. CLINICAL NUCLEAR MEDICINE
- 68Ga-labelled peptides in the management of neuroectodermal tumours
- (2012) Meeran Naji et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis
- (2012) Giorgio Treglia et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma
- (2012) David Taïeb et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Imaging Work-Up for Screening of Paraganglioma and Pheochromocytoma inSDHxMutation Carriers: A Multicenter Prospective Study from the PGL.EVA Investigators
- (2012) Anne-Paule Gimenez-Roqueplo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Modern Nuclear Imaging for Paragangliomas: Beyond SPECT
- (2012) D. Taieb et al. JOURNAL OF NUCLEAR MEDICINE
- Correlation of the Genotype of Paragangliomas and Pheochromocytomas with Their Metabolic Phenotype on 3,4-Dihydroxy-6-18F-Fluoro-L-Phenylalanin PET
- (2012) H. C. Rischke et al. JOURNAL OF NUCLEAR MEDICINE
- Staging and Functional Characterization of Pheochromocytoma and Paraganglioma by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography
- (2012) Henri J. L. M. Timmers et al. JNCI-Journal of the National Cancer Institute
- Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer
- (2012) Michaël Soussan et al. NUCLEAR MEDICINE COMMUNICATIONS
- Evaluation of LMI1195, a Novel 18 F-Labeled Cardiac Neuronal PET Imaging Agent, in Cells and Animal Models
- (2011) Ming Yu et al. Circulation-Cardiovascular Imaging
- Modern PET imaging for paragangliomas: Relation to genetic mutations
- (2011) D. Taïeb et al. EJSO
- Overexpression of the natural antisense hypoxia-inducible factor-1 transcript is associated with malignant pheochromocytoma/paraganglioma
- (2011) P. N. Span et al. ENDOCRINE-RELATED CANCER
- False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease
- (2011) Jay S Fonte et al. ENDOCRINE-RELATED CANCER
- Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status
- (2011) Graeme Eisenhofer et al. EUROPEAN JOURNAL OF CANCER
- Metastatic pheochromocytoma: Does the size and age matter?
- (2011) Tomáš Zelinka et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
- (2011) Nelly Burnichon et al. HUMAN MOLECULAR GENETICS
- Functional Imaging ofSDHx-Related Head and Neck Paragangliomas: Comparison of18F-Fluorodihydroxyphenylalanine,18F-Fluorodopamine,18F-Fluoro-2-Deoxy-d-Glucose PET,123I-Metaiodobenzylguanidine Scintigraphy, and111In-Pentetreotide Scintigraphy
- (2011) Kathryn S. King et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Updated Practice Guideline for Somatostatin Receptor Scintigraphy
- (2011) H. R. Balon JOURNAL OF NUCLEAR MEDICINE
- Incidence of Increased 68Ga-DOTANOC Uptake in the Pancreatic Head in a Large Series of Extrapancreatic NET Patients Studied with Sequential PET/CT
- (2011) P. Castellucci et al. JOURNAL OF NUCLEAR MEDICINE
- Patient-Specific Radiation Dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in Neuroendocrine Tumors
- (2011) J. Grimes et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma
- (2011) Vittoria Rufini et al. NUCLEAR MEDICINE COMMUNICATIONS
- Quantitative 177 Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system
- (2011) Jean-Mathieu Beauregard et al. CANCER IMAGING
- Low penetrance of a SDHB mutation in a large Dutch paraganglioma family
- (2010) Frederik J Hes et al. BMC Medical Genetics
- Comparison of [111In]pentetreotide-SPECT and [18F]FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalities
- (2010) N. Charrier et al. CLINICAL ENDOCRINOLOGY
- Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma
- (2010) G. Eisenhofer et al. ENDOCRINE-RELATED CANCER
- Increased uptake of [123I]meta-iodobenzylguanidine, [18F]fluorodopamine, and [3H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors
- (2010) L. Martiniova et al. ENDOCRINE-RELATED CANCER
- 131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging
- (2010) Emilio Bombardieri et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging
- (2010) Emilio Bombardieri et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Are we overestimating the penetrance of mutations in SDHB?
- (2010) Francesca Schiavi et al. HUMAN MUTATION
- The Use of Functional Imaging in a Patient with Head and Neck Paragangliomas
- (2010) Kathryn S. King et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- 6-18F-Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to123I-Metaiodobenzyl-Guanidine Scintigraphy in the Detection of Extraadrenal and Hereditary Pheochromocytomas and Paragangliomas: Correlation with Vesicular Monoamine Transporter Expression
- (2010) C. Fottner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Absorbed 18F-FDG Dose to the Fetus During Early Pregnancy
- (2010) P. Zanotti-Fregonara et al. JOURNAL OF NUCLEAR MEDICINE
- Research Resource: Transcriptional Profiling Reveals Different Pseudohypoxic Signatures in SDHB and VHL-Related Pheochromocytomas
- (2010) Elena López-Jiménez et al. MOLECULAR ENDOCRINOLOGY
- 68Ga-DOTA-TATE PET vs. 123I-MIBG in Identifying Malignant Neural Crest Tumours
- (2010) Meeran Naji et al. MOLECULAR IMAGING AND BIOLOGY
- Adverse allergic reaction to 131I MIBG
- (2009) Naoya Ishibashi et al. ANNALS OF NUCLEAR MEDICINE
- Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out
- (2009) H. P.H. Neumann et al. CANCER RESEARCH
- New imaging approaches to phaeochromocytomas and paragangliomas
- (2009) Bas Havekes et al. CLINICAL ENDOCRINOLOGY
- Penetrance and clinical consequences of a grossSDHBdeletion in a large family
- (2009) DC Solis et al. CLINICAL GENETICS
- Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma
- (2009) Markus Luster et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT
- (2009) Mohsen Beheshti et al. EUROPEAN RADIOLOGY
- Comparison of18F-Fluoro-L-DOPA,18F-Fluoro-Deoxyglucose, and18F-Fluorodopamine PET and123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma
- (2009) Henri J. L. M. Timmers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- 6-[F-18]Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess
- (2009) Helle-Brit Fiebrich et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- 18F-FDG Avidity of Pheochromocytomas and Paragangliomas: A New Molecular Imaging Signature?
- (2009) D. Taieb et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas
- (2009) F. Imani et al. JOURNAL OF NUCLEAR MEDICINE
- The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas
- (2009) Judith Favier et al. PLoS One
- Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET
- (2008) Stefano Fanti et al. BIOMEDICINE & PHARMACOTHERAPY
- The role of18F-FDOPA and18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas
- (2008) D. Taïeb et al. CLINICAL ENDOCRINOLOGY
- Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO)
- (2008) Henri J. L. M. Timmers et al. CLINICAL ENDOCRINOLOGY
- The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors
- (2008) Saila Kauhanen et al. ENDOCRINE-RELATED CANCER
- 111In-Octreotide Is Superior to 123I-Metaiodobenzylguanidine for Scintigraphic Detection of Head and Neck Paragangliomas
- (2008) K. P. Koopmans et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of 6-18F-Fluorodopamine PET with 123I-Metaiodobenzylguanidine and 111In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic Pheochromocytoma
- (2008) I. Ilias et al. JOURNAL OF NUCLEAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More